CADDI | Advances In Drug Development And Delivery: Innovation And Patient-Focus




Click here to register for the event.

Date: November 30. 2017

Location: Toronto, ON

Program Overview: 
Making the right choices is important in today’s R&D environment, especially considering the various pressures on developers such as time, resources, and funding. Short term thinking can lead to long term problems leading to missed timelines, escalating costs, and even regulatory issues in later phases. These factors can unfortunately contribute to non-optimal drug products unless they are addressed upfront by incorporating patient focused design principles to promote better drug performance and patient outcomes.

This event will focus on a number of key considerations for developing the best small or large molecule drug product for patients:
• Avoiding the biggest pitfalls in drug development
• Addressing biopharmaceutical challenges 
• Incorporating patient considerations in designing a drug product
• Latest trends and technologies for small and large molecule therapeutics

Exclusively for JLABS residents – Meet with a Catalent expert: Attendees have the opportunity to discuss their projects and challenges and learn about potential solutions in a 1-on-1 setting with a Catalent formulation or biologics expert. This is a complimentary opportunity for all attendees. Advanced scheduling is requested. Please email Ronak Savla (ronak.savla@catalent.com) or Dan Peizer (dan.peizer@catalent.com).

Program Agenda
8:00 am – 8:30 am | REGISTRATION & BREAKFAST 
8:30 am – 8:45 am | WELCOME & INTRODUCTION
Prof. Christine Allen, Professor and GSK Chair in Pharmaceutics and Drug Delivery, University of Toronto
Breanne Halyk, Innovation Activation Manager, JLABS Canada

SMALL MOLECULE DRUG DEVELOPMENT CONSIDERATIONS
8:45 am – 9:15 am | DELIVERING THE “PROMISE OF R&D” 
Dr. Cornell Stamoran, Founder, Catalent Institute
9:15 am – 10:00 am | FORMULATION TECHNOLOGIES TO OVERCOME ORAL BIOAVAILABILITY CHALLENGES OF SMALL MOLECULE DRUGS 
Mr. Stephen Tindal, Director, Science & Technology, Catalent Pharma Solutions
10:00 am – 10:15 am | BREAK 
10:15 am – 11:00 am | DESIGN OF AMORPHOUS SOLID DISPERSIONS FOR ENHANCING THE DELIVERY OF POORLY SOLUBLE DRUGS: EFFECT OF SOLUBLE VERSUS INSOLUBLE CARRIERS 
Prof. Ping Lee, Professor in Pharmaceutics and Drug Delivery, University of Toronto
11:00 am – 12:00 pm | PATIENT FOCUSED DOSE FORM DESIGN 
Dr. Cornell Stamoran, Founder, Catalent Institute
12:00 pm – 1:30 pm | NETWORKING LUNCH & MEET THE EXPERTS

LARGE MOLECULE DRUG DEVELOPMENT CONSIDERATIONS
Chair by Prof. Isabelle Aubert, Professor Laboratory Medicine and Pathobiology, University of Toronto
12:00 pm – 1:30 pm | REGISTRATION, NETWORKING LUNCH & MEET THE EXPERTS 
1:30 pm – 2:15 pm | EFFICIENT EXPRESSION OF COMPLEX PROTEINS IN MAMMALIAN CELLS 
Dr. Greg Bleck, Global Head R&D, Biologics, Catalent Biologics
2:15 pm – 3:00 pm | ANTIBODY-DRUG CONJUGATES 
Dr. David Rabuka, Global Head R&D, Chemical Biology, Catalent Biologics
3:00 pm – 3:15 pm | BREAK 
3:15 pm – 4:00 pm | TBA- Synthetic antibodies and immuno-oncology 
Dr. Jarrett Adams, Associate Director, Toronto Recombinant Antibody Centre 
4:00 pm – 5:00 pm | PANEL DISCUSSION 
Moderated by Prof. Isabelle Aubert
5:00 pm | CLOSING REMARKS 
Meet with a Catalent expert: Attendees have the opportunity to discuss their projects and challenges and learn about potential solutions in a 1-on-1 setting with a Catalent formulation or biologics expert. This is a complimentary opportunity for all attendees. Advanced scheduling is requested. Details to follow.

original

Click here to register for the event.